Compare ADMA Biologics Inc (ADMA) vs F5 Inc (FFIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs F5 Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while F5 Inc trades at $414 (market cap $23.44B). The key difference: F5 Inc is far larger — about 10.6× ADMA Biologics Inc's market cap, and F5 Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | FFIV | |
|---|---|---|
Market Cap | $2.22B | $23.44B |
Sector | Health | Technology |
52-Week High | $20.38 | $431.26 |
52-Week Low | $7.60 | $223.99 |
Enterprise Value | $2.29B | $22.08B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About F5 Inc
F5 is a market leader in the application delivery controller market. The company sells products for networking traffic, security, and policy management. Its products ensure applications are safely routed in efficient manners within on-premises data centers and across cloud environments. More than half of its revenue is based on providing services, and its three customer verticals are enterprises, service providers, and government entities. The Seattle-based firm was incorporated in 1996 and generates sales globally.
Read more on FFIV →
